SARS-CoV-2 (2019-nCoV)
ELISA, Neutralization
Human
IgG1, kappa
Iv0221
SARS-CoV-2 (2019-nCoV)
ELISA, Neutralization
Human
IgG1, kappa
Iv0222
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Neutralization
Human
IgG1, kappa
CC40.8
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Neutralization
Human
IgG1, kappa
m336
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Research Grade Biosimilar
Human
IgG1-lambda
SARS-CoV-2
Research Grade Biosimilar
Human
IgG1
BD55-5514
SARS-CoV-2 (2019-nCoV)
Research Grade Biosimilar
Human
IgG1
COV44-62
SARS-CoV-2 (2019-nCoV)
Research Grade Biosimilar
Human
IgG1, lambda2
SARS-CoV-2 (2019-nCoV)
Research Grade Biosimilar
Human
IgG1
P2B-2F6
E. coli
P0DTD1
Asp4891-Val5212
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)